Advanced Vinyl Pyrrolidone Testing Services

Real‑Time PCR (qPCR) Detection and Quantification

An internationally recognized testing institution, assisting enterprises in achieving technological advancement.

Reasons for choosing our testing services

ZHONGXI Testing has obtained inspection qualification certifications from multiple countries and regions worldwide. We possess a senior testing team and advanced testing methods, providing independent, impartial, and professional third-party verification services for global carbon projects.

Internationally recognized authority

Internationally recognized authority

Certified by multiple international standards such as CNAS, VCS, and GS, with reports universally applicable worldwide.

Global service capability

Global service capability

Covering 140+ countries and regions, it supports on-site detection and remote verification in multiple languages.

Professional experimental methods

Professional experimental methods

Adopt standard experimental methods to ensure accurate and reliable data.

Advanced Real‑Time PCR (qPCR) Detection and Quantification Services – From Gene Expression Profiling to Low‑Level Pathogen Quantification

The adoption of real‑time polymerase chain reaction (real‑time PCR, qPCR) has revolutionised the field of nucleic acid analysis, offering unparalleled sensitivity, specificity, and quantitative accuracy for the detection and quantification of DNA targets across a wide range of applications. From gene expression analysis and viral load monitoring to food pathogen detection, environmental surveillance, and genetically modified organism (GMO) testing, qPCR has become an indispensable tool in diagnostic, research, and regulatory settings. However, the successful application of qPCR is not achieved by simply running a standard protocol; it critically depends on the quality of the sample, the efficiency of nucleic acid extraction, the specificity of the primer and probe design, the optimisation of reaction conditions, and the robustness of the data analysis. Moreover, the interpretation of qPCR results must account for amplification efficiency, the presence of inhibitors, and the dynamic range of the assay. Regulatory frameworks, such as the MIQE guidelines (Minimum Information for Publication of Quantitative Real‑Time PCR Experiments), require comprehensive documentation of all experimental parameters to ensure reproducibility and comparability. Our ISO/IEC 17025‑accredited and GMP‑compliant laboratory offers a fully integrated qPCR testing platform, encompassing all stages from experimental design and sample preparation to amplification, data analysis, and interpretation. We deliver quantitative, traceable data, including absolute and relative quantification, with full compliance to MIQE and other relevant guidelines. We provide expert interpretation and regulatory support, enabling you to obtain robust, reliable, and defensible results for your specific application, whether it is for research, product release, or regulatory submission.

Real‑Time PCR (qPCR) Detection and Quantification

1. The Scientific and Regulatory Rationale for Rigorous qPCR Testing

Real‑time PCR is used for a wide variety of purposes: (a) gene expression analysis (e.g., mRNA quantification); (b) detection and quantification of pathogens (bacteria, viruses, fungi); (c) copy number variation (CNV) analysis; (d) transgene copy number determination; (e) viral load monitoring (e.g., HIV, HBV, HCV); (f) food authenticity and GMO testing; and (g) environmental monitoring. The choice of method – whether SYBR Green‑based (intercalating dye) or TaqMan probe‑based (sequence‑specific) – must be tailored to the target, the required specificity, and the degree of quantification needed (absolute vs. relative). Regulatory guidelines (e.g., ICH Q2(R1) for validation of analytical procedures, and the MIQE guidelines for publication) require that the assay be thoroughly validated, including the determination of linearity, dynamic range, limit of detection (LOD), limit of quantification (LOQ), precision, and accuracy. Our service begins with a comprehensive consultation to design the optimal qPCR strategy for your specific application and to ensure that the validation plan meets your regulatory and quality requirements.

2. Our Comprehensive qPCR Testing Platform – From Sample to Result

We maintain a complete suite of validated qPCR workflows, all performed in a dedicated, contamination‑controlled laboratory environment, and with certified reference materials and positive controls. Our portfolio includes:

2.1 Nucleic Acid Extraction and Purification – The Foundation of Reliable qPCR
We use high‑quality extraction methods (e.g., spin‑column, magnetic bead‑based, or automated extraction systems) to isolate DNA or RNA from a wide range of sample types: biological fluids, tissues, cells, foods, environmental samples, and swabs. We incorporate internal controls (e.g., spiked RNA or DNA) to monitor extraction efficiency and to detect the presence of inhibitors. For RNA targets, we perform DNase treatment to eliminate genomic DNA contamination, and we include a reverse transcription step (RT‑qPCR) using either random primers or oligo‑dT, depending on the target.

2.2 Assay Design and Optimisation – Specificity and Sensitivity
Our team designs and optimises primer and probe sets targeting your specific gene or genetic region, using a combination of bioinformatics tools and empirical testing. We evaluate primer efficiency, specificity (via melting curve analysis or probe discrimination), and the absence of secondary structures (e.g., hairpins, dimers). We test the assay across a range of annealing temperatures and magnesium concentrations to determine the optimal conditions for maximum sensitivity and specificity. We also design multiplex assays that can simultaneously quantify multiple targets in a single reaction (e.g., a target gene and a reference gene).

2.3 Absolute Quantification – Generation of Standard Curves
For absolute quantification (e.g., viral load, transgene copy number), we construct standard curves using either synthetic DNA (gBlocks) or purified plasmid DNA, or by using quantified genomic DNA standards. We perform serial dilutions across a minimum of 5‑6 log10 orders of magnitude to define the linear dynamic range and to determine the limit of detection (LOD) and limit of quantification (LOQ). The standard curve is run in each assay plate to correct for any plate‑to‑plate variation.

2.4 Relative Quantification – Gene Expression Analysis
For gene expression studies, we perform relative quantification using a reference gene (e.g., GAPDH, β‑actin, or 18S rRNA) and calculate the ΔΔCt method or use the Pfaffl method to account for variations in amplification efficiency between the target and reference genes. We also evaluate the stability of the reference gene(s) using statistical methods (e.g., geNorm, NormFinder) to ensure valid normalisation.

2.5 Multiplexing – Detection of Multiple Targets in One Reaction
We offer multiplex qPCR using differentially labelled probes (e.g., FAM, VIC, ROX, Cy5) to detect up to 4‑5 targets in a single well. This is particularly useful for distinguishing between different serotypes of a pathogen, for normalising to a reference gene, or for detecting both a target and an internal control in the same reaction.

2.6 Quality Control and Data Analysis – Rigorous Interpretation
Each qPCR run includes: (i) a no‑template control (NTC) to monitor for contamination; (ii) a no‑reverse‑transcription control (NRT) for RNA targets; and (iii) a positive control (PC) of known concentration. We analyse the amplification curves using software‑based threshold determination (manual and automatic) to ensure accurate Ct/Cq values. We check the amplification efficiency from the standard curve (acceptable range: 90‑110%), and we apply outlier detection to exclude any anomalous replicates.

3. Advanced Capabilities – Method Development, Validation, and Custom Assays

For clients requiring a deeper understanding or a high‑level validation of their qPCR assay, we offer a suite of customised, research‑grade services that go beyond routine testing:

3.1 Comprehensive Assay Validation (ICH Q2(R1) and MIQE Compliant)
We conduct full method validation for your qPCR assay, including: (a) linearity (over the expected quantification range); (b) accuracy (by spike‑and‑recovery experiments); (c) precision (intra‑ and inter‑assay repeatability); (d) specificity (cross‑reactivity with closely related sequences); (e) limit of detection (LOD) and limit of quantification (LOQ); and (f) robustness to variations in reaction components and thermal cycling conditions. The validation report is structured for regulatory submissions (e.g., in a CTD format).

3.2 Digital PCR (dPCR) – Absolute Quantification Without a Standard Curve
For applications where absolute quantification is required without relying on a standard curve (e.g., for reference materials, or for accurate low‑level detection), we offer droplet digital PCR (ddPCR). This technique partitions the sample into thousands of droplets, enabling the absolute determination of target copies per volume, with higher precision than qPCR, particularly at low concentrations.

3.3 RNA Expression Profiling – Custom Panels and Whole‑Transcriptome Screening
We can design custom qPCR arrays for the quantification of up to 96‑384 targets in a single run, enabling the assessment of specific gene panels (e.g., inflammatory markers, drug‑metabolising enzymes, or oncogenes). For a broader view, we also offer whole‑transcriptome screening using RNA‑seq (with qPCR validation of selected targets).

3.4 Inhibitor and Matrix Effect Assessment – Sample Suitability Testing
We assess the presence of PCR inhibitors (e.g., humic acids, heparin, haemoglobin, or polysaccharides) by performing spike‑and‑recovery experiments and by using internal amplification controls (IACs). If inhibition is detected, we develop customised sample pre‑treatment (e.g., dilution, clean‑up, or the use of specific polymerase enzymes) to ensure reliable amplification.

3.5 Single‑Cell and Low‑Input qPCR
For samples with limited material (e.g., fine needle aspirates, biopsies, circulating tumour cells, or single cells), we offer single‑cell qPCR (after pre‑amplification) or low‑input qPCR with optimised protocols to maximise sensitivity and to minimise the effects of dilution.

3.6 Mutation Detection – Allelic Discrimination and SNP Genotyping
We perform allele‑specific qPCR (using TaqMan probes with different fluorophores for each allele) to detect single nucleotide polymorphisms (SNPs) or point mutations (e.g., the BRAF V600E mutation, or ras mutations). The assay is designed to discriminate between the wild‑type and mutant sequences with high specificity.

4. Data Integrity, Standardisation, and Comprehensive Reporting

All analyses are conducted under a strict quality management system that includes the use of certified reference materials, routine calibration of instruments, and participation in proficiency testing schemes (e.g., UK NEQAS, or APHL). Our reports provide:

  • Full method description – including extraction protocol, primer/probe sequences, reaction conditions (annealing temperature, Mg²⁺ concentration, cycling parameters), and the data analysis algorithm (threshold setting, baseline correction).
  • Quantitative results – with Ct/Cq values, concentration (in copies/µL, IU/mL, or relative units), and expanded uncertainty (k=2) where applicable.
  • Validation data – including efficiency, linearity, LOD, LOQ, and precision, with a clear statement of the assay’s performance.
  • Interpretative comments – on the significance of the results, including the detection/quantification level, any observed inhibition, and any corrective actions recommended.

Our reports are authored by senior molecular biologists and bioinformaticians who provide not just raw data, but actionable insights to guide your quality and scientific decisions.

Turnaround times: 3‑5 working days for standard qPCR analysis (including extraction), 2‑3 weeks for full method validation, and 1‑2 weeks for custom assay development. Express services are available for urgent projects.

5. Our Unmatched Expertise – Why Choose Our Laboratory for qPCR Testing

We are one of the few laboratories that hold ISO/IEC 17025 accreditation and GMP compliance for qPCR testing, covering both SYBR Green and TaqMan chemistries, and for a wide range of sample types. Our integrated infrastructure combines high‑quality nucleic acid extraction, advanced thermal cycling instruments (e.g., Bio‑Rad CFX96, Applied Biosystems 7500, and QuantStudio 12K Flex), and automated data analysis pipelines – enabling cross‑verification and rapid resolution of ambiguous results. Our team comprises PhD‑level molecular biologists, biostatisticians, and bioinformaticians with extensive experience in assay design, method validation, and regulatory submissions, and we have a proven track record of supporting projects in diagnostic development, pharmaceutical release, and research programmes.

We offer unparalleled flexibility: we accept all sample types – from biological fluids and tissues to food, environmental samples, and swabs – and we provide customised sampling kits with stabilising agents to preserve nucleic acid integrity. Our secure online portal enables real‑time tracking, access to raw data, and downloadable certificates.

Our modular pricing ensures cost‑effectiveness: you select the level of analysis – from a simple screening to a full validation – with discounts for routine monitoring programmes and bulk submissions. We also provide training, method transfer, and technical consultancy to help you build or strengthen your internal qPCR testing capability.

With a proven history of serving over 90 clients in diagnostics, pharmaceuticals, food safety, and environmental monitoring, we have enabled our partners to ensure product quality, achieve regulatory compliance, and accelerate project timelines. We invite you to leverage our expertise for your qPCR testing needs.

Contact our technical experts today to discuss your target applications, sample types, and regulatory requirements. We will design a tailored testing plan and provide a detailed proposal within one business day.

Submit detection request

Fill in the information to obtain a professional testing plan

About Us

Beijing ZKGX Institute of Science and Technology , combining applied research with technological transformation. It has evolved into a comprehensive research institute characterized primarily by a "task-driven disciplines" approach. Approved by relevant authorities, it currently operates as a third-party analytical testing technical service provider. Its affiliated laboratory facilities hold certifications including CMA and CNAS, possess an Experimental Animal Use License, and have achieved triple certification for ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.